Overview

Neostigmine and Dexamethasone in Adductor Canal Block

Status:
Recruiting

Trial end date:
2021-10-30

Target enrollment:

Participant gender:

Summary

To compare between the efficacy of neostigmine and dexamethasone as an adjuvant to bupivacaine in adductor canal block after knee arthroscopy surgery.

Phase:

N/A

Details

Lead Sponsor:

Cairo University

Treatments:

Dexamethasone
Neostigmine